Literature DB >> 10980993

Cancer surveillance in inflammatory bowel disease.

C N Bernstein1.   

Abstract

This article reviews the rationale and approach to dysplasia surveillance colonoscopy in inflammatory bowel disease. Recent developments in the field are also highlighted, including approaches to polyps that arise in patients with colitis and new diagnostic markers that may complement morphologic assessment for dysplasia.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10980993     DOI： 10.1007/s11894-999-0010-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN： 1522-8037


  40 in total

1.  Colorectal cancer in inflammatory bowel disease: a continuing problem.

Authors:  R Mayer; W D Wong; D A Rothenberger; S M Goldberg; R D Madoff
Journal:  Dis Colon Rectum       Date:  1999-03       Impact factor: 4.585

2.  Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study.

Authors:  D Pinczowski; A Ekbom; J Baron; J Yuen; H O Adami
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

3.  Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia.

Authors:  R F Willenbucher; D E Aust; C G Chang; S J Zelman; L D Ferrell; D H Moore; F M Waldman
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

4.  The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis.

Authors:  B A Lashner; K S Provencher; D L Seidner; A Knesebeck; A Brzezinski
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

5.  Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis.

Authors:  K Holzmann; B Klump; F Borchard; C J Hsieh; A Kühn; V Gaco; M Gregor; R Porschen
Journal:  Int J Cancer       Date:  1998-03-30       Impact factor: 7.396

6.  Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: relation to dysplasia and DNA aneuploidy.

Authors:  P Karlén; E Young; O Broström; R Löfberg; B Tribukait; K Ost; C Bodian; S Itzkowitz
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

7.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

Authors:  W R Connell; J E Lennard-Jones; C B Williams; I C Talbot; A B Price; K H Wilkinson
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

8.  Physicians' perceptions of dysplasia and approaches to surveillance colonoscopy in ulcerative colitis.

Authors:  C N Bernstein; W M Weinstein; D S Levine; F Shanahan
Journal:  Am J Gastroenterol       Date:  1995-12       Impact factor: 10.864

9.  Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas.

Authors:  F Fogt; A O Vortmeyer; M Stolte; E Mueller; J Mueller; A Noffsinger; C Poremba; Z Zhuang
Journal:  Hum Pathol       Date:  1998-09       Impact factor: 3.466

10.  von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens.

Authors:  Z Zhuang; M R Emmert-Buck; M J Roth; J Gnarra; W M Linehan; L A Liotta; I A Lubensky
Journal:  Hum Pathol       Date:  1996-02       Impact factor: 3.466
View more
  1 in total

1.  Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age.

Authors:  Constantine J Karvellas; Richard N Fedorak; John Hanson; Clarence K W Wong
Journal:  Can J Gastroenterol       Date:  2007-07       Impact factor: 3.522
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.